Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Optimizing Tarlatamab Delivery in Small Cell and Neuroendocrine Lung Cancer: Real-World Insights into Step-Up Dosing and Prophylactic Tocilizumab Use.
Journal: Clinical lung cancer
Published: September 21, 2025
Outcomes of Patients With Newly Diagnosed AML and Hyperleukocytosis.
Journal: JCO oncology practice
Published: July 16, 2024
Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms.
Journal: Cancer medicine
Published: July 28, 2023
A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents.
Journal: Journal of hematology & oncology
Published: May 26, 2023
Current Understanding of DDX41 Mutations in Myeloid Neoplasms.
Journal: Cancers
Published: August 19, 2022
Venetoclax resistance: mechanistic insights and future strategies.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: November 20, 2021
Showing 1-7 of 7
Last Updated: 09/26/2026